MITRA — Mithra Pharmaceuticals SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Mithra Pharmaceuticals SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	96.5	9.03	22.7	67	40.2
Cost of Revenue
Gross Profit	94	5.57	6.94	47.4	18.2
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	69.5	92.7	111	93.2	179
Operating Profit	27	-83.7	-87.9	-26.2	-139
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-31.4	-111	-124	-11.5	-162
Provision for Income Taxes
Net Income After Taxes	-26.6	-92.1	-117	-59.6	-174
Net Income Before Extraordinary Items
Net Income	-26.6	-92.1	-117	-59.6	-174
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-26.6	-92.1	-117	-59.6	-174
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.704	-2.19	-2.69	-1.22	-1.81